Loading...
PhD Urška Kamenšek

PhD Urška Kamenšek
no.: 28387 source: ARIS

researcher – active in research organisation
E-mail ukamensekat signonko-i.si
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
3.01.00  Medical sciences  Microbiology and immunology   
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Points
607.81
A''
131.91
A'
263.44
A1/2
326.12
CI10
489
CImax
78
h10
12
A1
2.11
A3
3.92
Data for the last 5 years (citations for the last 10 years) on June 13, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 57  825  448  7.86 
Scopus 52  907  532  10.23 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 PhD Tinkara Remic  Bologna doctoral studies  10/1/2017 - 9/30/2022  50593 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Biotechnical Faculty 2005 
Doctor's degree  Ph. D.     SI University of Ljubljana, Faculty of Medicine 2010 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:100%)  Institute of Oncology Ljubljana  Department of research  11/1/2006  Analyst  Researcher   
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J3-50108  DEBIO 1143 has a potential to increase effectiveness of electrochemotherapy and radiotherapy in HPV positive and HPV negative Head and Neck Cancers   2023 - 2024  PhD Katarina Žnidar  2,208 
2. L3-50111  Gene immuno-therapy of solid tumors based on mRNA encoding interleukin-12: So-rIL   2023 - 2024  PhD Maja Čemažar  2,849 
3. J3-50110  Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept   2023 - 2024  PhD Katja Uršič Valentinuzzi  3,112 
4. J2-50068  Safety and efficacy of high frequency electrochemotherapy - clinical device development   2023 - 2024  PhD Matej Reberšek  3,487 
5. L7-4491  Development of integrated multi-channel artificial nose for detection of cancer   2022 - 2024  PhD Igor Muševič  5,502 
6. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   2022 - 2024  PhD Lucija Peterlin Mašič  6,100 
7. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   2021 - 2024  PhD Gregor Serša  6,811 
8. J3-9269  Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in patients undergoing electrochemotherapy   2018 - 2021  PhD Gregor Serša  3,526 
9. J3-8202  Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and Interleukin-12 gene therapy boost   2017 - 2020  PhD Maja Čemažar  3,562 
10. J1-6730  Development of new hepatic cell lines for genotoxicity and carcinogenicity studies: new hope for human health and laboratory animal welfare protection   2014 - 2017  PhD Metka Filipič  4,071 
11. J3-6793  New approaches of tumor radiosenzibilization with gene therapy   2014 - 2017  PhD Gregor Serša  5,119 
12. J3-6796  Translational oncology: development and validtion of immunogene therapy with Interleukin-12 combined with surgery for canine cancers of the oral cavity and skin   2014 - 2017  PhD Maja Čemažar  4,772 
13. J3-5505  Electrochemotherapy in treatment of deep seated tumors   2013 - 2016  PhD Gregor Serša  4,292 
14. J3-4211  Antiangiogenic gene therapy of cancer using electroporation and magnetic nanoparticles as targeted delivery systems   2011 - 2014  PhD Gregor Serša  6,490 
15. J1-4044  Apoptotic effects of alkylpyridinium compounds on lung adenocarcinoma cells   2011 - 2014  PhD Tom Turk  6,296 
16. J3-4259  Preparation and validation of therapeutic plasmids without selection gene for antibiotic resistance for cancer gene therapy using inducible and tissue-specific promoters   2011 - 2014  PhD Maja Čemažar  5,890 
17. J1-4131  Synthesis, characterisation and use of novel ruthenium compounds in electrochemotherapy of tumors   2011 - 2014  PhD Iztok Turel  5,967 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P3-0003  Development and evaluation of new approaches to cancer treatment   2022 - 2024  PhD Gregor Serša  3,971 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   2015 - 2021  PhD Gregor Serša  3,283 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   2009 - 2014  PhD Gregor Serša  4,042 
Views history
Favourite